Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors

Human Gene Therapy

Volumn 9, Issue 4, 1998, Pages 477-485

  Manning, William C ^a   Zhou, Shangzhen ^a   Bland, Mary Pat ^a   Escobedo, Jaime A ^a   Dwarki, Varavani ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CAPSID PROTEIN; GLYCOPROTEIN GP 39; NEUTRALIZING ANTIBODY; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE THERAPY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; MOUSE; MUSCLE; NONHUMAN; TISSUE; TRANSGENE; VIRUS CAPSID;

ADENOVIRIDAE; ANIMALIA; MIRIDAE;

EID: 0032031816     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.4-477     Document Type: Article

References (9)

1. AFIONE, S.A., CONRAD, C.K., KEARNS, W.G., CHUNDURU, S., ADAMS, R., REYNOLDS, T.C., GUGGINO, W.B., CUTTING, G.R., CARTER, B.J., and FLOTTE, T.R. (1996). In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70, 3235-3241.
2. BLACKLOW, N.R., HOGGAN, M.D., and ROWE, W.P. (1968). Serologic evidence for human infection with adeno-associated viruses. J. Natl. Cancer Inst. 40, 319-327.
3. CLARK, K.R., SFERRA, T.J., and JOHNSON, P.R. (1997). Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8, 659-669.
4. CONRAD, C.K., ALLEN, S.S., AFIONE, S.A., REYNOLDS, T.C., BECK, S.E., FEE-MAKI, M., BARRAZZA-ORTIZ, X., ADAMS, R., ASKIN, F.B., CARTER, B.J., GUGGINO, W.B., and FLOTTE, T.R. (1996). Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 3, 658-668.
5. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W., SARVETNICK, N., and VERMA, I. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
6. DURIE, F.H., FOY, T.M., MASTERS, S.R., LAMAN, J.D., and NOELLE, R.J. (1994). The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15, 406-411.
7. FISHER, K.J., JOOSS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 3, 306-312.
8. FLANNERY, J.G., ZOLOTUKHIN, S., VAQUERO, M.I., LaVAIL, M.M., MUZYCZKA, N., and HAUSWIRTH, W.W. (1997). Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94, 6916-6921.
9. + cytolytic T cells. Nature 344, 742-746.